UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 382

Sortiert nach

Synthesis and evaluation of bisbenzylidenedioxotetrahydrothiopranones as activators of endoplasmic reticulum (ER) stress signaling pathways and apoptotic cell death in acute promyelocytic leukemic cells

Journal of medicinal chemistry, 2014-07, Vol.57 (14), p.5904-5918

2014

Volltextzugriff (PDF)

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Nature (London), 2013-05, Vol.497 (7447), p.108-112

2013

Volltextzugriff (PDF)

Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression

Nature communications, 2016-06, Vol.7 (1), p.11702-11702, Article 11702

2016

Volltextzugriff (PDF)

Reduced Erlotinib Sensitivity of Epidermal Growth Factor Receptor-Mutant Non–Small Cell Lung Cancer following Cisplatin Exposure: A Cell Culture Model of Second-line Erlotinib Treatment

Clinical cancer research, 2008-11, Vol.14 (21), p.6867-6876

2008

Volltextzugriff (PDF)

Dioxonaphthoimidazoliums are Potent and Selective Rogue Stem Cell Clearing Agents with SOX2-Suppressing Properties

ChemMedChem, 2016-09, Vol.11 (17), p.1944-1955

2016

Volltextzugriff (PDF)

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer

EMBO molecular medicine, 2018-03, Vol.10 (3), p.n/a

2018

Volltextzugriff (PDF)

Fatal cystic change of brain metastasis after response to gefitinib in non-small-cell lung cancer

Journal of clinical oncology, 2009-10, Vol.27 (30), p.e145-e146

2009

Volltextzugriff (PDF)

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer

EMBO molecular medicine, 2018-06, Vol.10 (6), p.n/a

2018

Volltextzugriff (PDF)

EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib--Letter

Molecular cancer therapeutics, 2013-11, Vol.12 (11), p.2614-2615

2013

Volltextzugriff (PDF)

CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer

Theranostics, 2019-01, Vol.9 (21), p.6157-6174

2019

Volltextzugriff (PDF)

Management of epidermal growth factor receptor tyrosine kinase inhibitor‐related cutaneous and gastrointestinal toxicities

Asia-Pacific journal of clinical oncology, 2018-02, Vol.14 (1), p.23-31

2018

Volltextzugriff (PDF)

Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography–tandem mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2012-03, Vol.61, p.86-92

2012

Volltextzugriff (PDF)

Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2013-05, Vol.71 (5), p.1325-1334

2013

Volltextzugriff (PDF)

Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors

Theranostics, 2020-01, Vol.10 (6), p.2727-2743

2020

Volltextzugriff (PDF)

Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians

Cancer detection and prevention, 2005-01, Vol.29 (5), p.412-418

2005

Volltextzugriff (PDF)

Targeting microtubule sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors

Theranostics, 2020, Vol.10 (6), p.2727-2743

2020

Volltextzugriff (PDF)

Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011-07, Vol.879 (22), p.2155-2161

2011

Volltextzugriff (PDF)

Evidence for Disease Control with Erlotinib after Gefitinib Failure in Typical Gefitinib-Sensitive Asian Patients with Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-04, Vol.3 (4), p.400-404

2008

Volltextzugriff (PDF)

How many adenocarcinoma lung cancers come from bronchioloalveolar carcinoma?

Thoracic cancer, 2011-05, Vol.2 (2), p.54-60

2011

Volltextzugriff (PDF)

Detection of Epidermal Growth Factor Receptor Variations by Partially Denaturing HPLC

Clinical chemistry (Baltimore, Md.), 2007-01, Vol.53 (1), p.62-70

2007

Volltextzugriff (PDF)

A classical case of non-bacterial thrombotic endocarditis from pancreatic adenocarcinoma presenting as multiple strokes, myocardial infarction and acute limb ischaemia

Oxford Medical Case Reports, 2016-11, Vol.2016 (11), p.omw084

2016

Volltextzugriff (PDF)

Lung Cancer Response to Gefitinib, Then Erlotinib, Then Gefitinib Again

Journal of thoracic oncology, 2008-09, Vol.3 (9), p.1077-1078

2008

Volltextzugriff (PDF)

PP01.74 LiquidHALLMARK detects more tissue-confirmed guideline-recommended biomarkers than Guardant360 for lung cancer: a prospective multicenter study

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.e34-e35

2024

Volltextzugriff (PDF)

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer

Nature medicine, 2012-04, Vol.18 (4), p.521-528

2012

Volltextzugriff (PDF)

1 – 25 von 382

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(333)
Mit Volltextzugriff
(353)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(237)
Life Sciences & Biomedicine
(187)
Humans
(139)
Female
(53)
Oncology
(50)
Male
(49)
Middle Aged
(35)
Medicine
(32)
Adult
(31)
Aged
(31)
Surgery
(29)
Patients
(27)
Technology
(27)
Animals
(26)
Medicine & Public Health
(26)
Physical Sciences
(24)
Science & Technology - Other Topics
(24)
Cancer
(22)
General & Internal Medicine
(21)
Medicine, General & Internal
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Synthesis and evaluation of bisbenzylidenedioxotetrahydrothiopranones as activators of endoplasmic reticulum (ER) stress signaling pathways and apoptotic cell death in acute promyelocytic leukemic cells

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer

Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression

Reduced Erlotinib Sensitivity of Epidermal Growth Factor Receptor-Mutant Non–Small Cell Lung Cancer following Cisplatin Exposure: A Cell Culture Model of Second-line Erlotinib Treatment

Dioxonaphthoimidazoliums are Potent and Selective Rogue Stem Cell Clearing Agents with SOX2-Suppressing Properties

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer

Fatal cystic change of brain metastasis after response to gefitinib in non-small-cell lung cancer

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer

EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib--Letter

CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer

Management of epidermal growth factor receptor tyrosine kinase inhibitor‐related cutaneous and gastrointestinal toxicities

Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography–tandem mass spectrometry

Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors

Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians

Targeting microtubule sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors

Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography–tandem mass spectrometry

Evidence for Disease Control with Erlotinib after Gefitinib Failure in Typical Gefitinib-Sensitive Asian Patients with Non-small Cell Lung Cancer

How many adenocarcinoma lung cancers come from bronchioloalveolar carcinoma?

Detection of Epidermal Growth Factor Receptor Variations by Partially Denaturing HPLC

A classical case of non-bacterial thrombotic endocarditis from pancreatic adenocarcinoma presenting as multiple strokes, myocardial infarction and acute limb ischaemia

Lung Cancer Response to Gefitinib, Then Erlotinib, Then Gefitinib Again

PP01.74 LiquidHALLMARK detects more tissue-confirmed guideline-recommended biomarkers than Guardant360 for lung cancer: a prospective multicenter study

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer

Suchergebnisse filtern